Theranica’s C Round Nets $45M

Koch Disruptive Technologies led, and was joined by insiders Bessemer Venture Partners, Flare Capital Partners, Frist Cressey Ventures, CVS Health Ventures and Takeda Digital Ventures.

The investment will enable InnovaCare to scale its physician-led model to enter key markets nationwide.

In addition to Oak HC/FT, Main Street's investors in this round include the five largest national Medicare Advantage plans, who collectively serve over 74% of Medicare Advantage members in the country. The round also includes investment from many of Main Street's provider partners including large health systems, regional hospitals, and individual primary care physicians.